Dr. Jeffrey Zonder and Dr. Aditi Sharma Karmanos Cancer Institute kicking off MSHO Precision Oncology Symposium Shirish Gadgeel with a fantaatic caae discussion for MM

Just completed one week with the Benign Hematology Service. A big thank you to my attending, Dr. Richa Parikh Richa Parikh. Truly inspired by her deep passion for myeloma and BMT, which has propelled her to a professorship at the prestigious Emory! Emory School of Medicine

Our model demonstrates feasibility and safety of outpatient administration for BsAb step-up dosing with appropriate patient selection, multidisciplinary collaboration and prophy toci! Winship Cancer Institute of Emory University Sagar Lonial MD Ajay Nooka, MD, MPH clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

Excited to share that our article on changing pneumonectomy rates in the era of Chemoimmunotherapy in resectable NSCLC is now published ! Thanks to my mentors for the opportunity and mentorship! Ibrahim Azar, MD Misako Nagasaka Hari B. Keshava Richa Parikh Karmanos Hematology/Oncology Fellowship UC Irvine

Look forward to presenting at the dietary forum - testing diet with the rigor of drug at 5 pm today at #AACR25 AACR with Marcus Goncalves and Jennifer McQuade Come join us for this discussion! Memorial Sloan Kettering Cancer Center MSK Department of Medicine

Thank you very much.

The fascinating story of Thalidomide: how this most notorious drug on the planet, banned in the 1960s, made an incredible comeback and revolutionized the treatment of myeloma. I will also highlight one person whose role is not recognized: Without Dr. Leif Bergsagel there will

Great news! FDA ODAC panel voted 6–2 YES on: “Do AQUILA trial results support a favorable benefit-risk for Dara-SC in high-risk smoldering myeloma?” IMF SAB members Drs. Vincent Rajkumar & Sagar Lonial MD shared expert insights. Learn more: mmsm.link/4kujklH

Press Release International Myeloma Foundation (IMF) to Honor 2025 Kyle and Durie Achievement Awardees, Dr. Sagar Lonial and Dr. Sonja Zweegman globenewswire.com/news-release/2…

My dear friend and colleague Dr. Sagar Lonial MD wins the Robert A. Kyle Lifetime Achievement Award! #IMWG25 A very moving ceremony today. Sagar, flanked by Nikhil C. Munshi, MD and Ken Anderson.

Such a wonderful evening and I was overwhelmed by the kindness of my colleagues

🎉Winship Chief Medical Officer Sagar Lonial, MD, FACP, FASCO, (Sagar Lonial MD) has been named the 2025 recipient of the Robert A. Kyle Lifetime Achievement Award in recognition of his contributions to advancing treatment and research in multiple myeloma. brnw.ch/21wTm7I

Honored to be named a 2025 Hematology Research All-Star! This recognition by @Avant-garde Health highlights the top 5% of physicians for impactful research. Grateful to my collaborators and mentors, this is a shared achievement! BU Amyloidosis Center Boston Medical Center Boston U Chobanian & Avedisian School of Medicine

Excellent out-reach by IMS to expand education and develop global co-operation

Winship hematologist and medical oncologist Sagar Lonial, MD, FACP, FASCO, (Sagar Lonial MD) begins the myeloma session at #DDHO2025 with a discussion on smoldering multiple myeloma: what we know and where we are going.

At #DDHO2025, Winship hematologist and medical oncologist Nisha Joseph, MD, explores Quadruplets vs Triplets for Elderly Patients with Multiple Myeloma.

🔍 DEBATE at #DDHO2025: Optimal Patient Phenotype in Relapsed Multiple Myeloma 🧬 CAR T-Cells – Ajay K. Nooka, MD, MPH, FACP 🧫 Bispecific Antibodies – Nisha Joseph, MD A timely discussion on matching therapies to the right patients in relapsed MM.

At #DDHO2025, Winship hematologist and medical oncologist Jonathan Kaufman, MD, discusses how MRD is reshaping treatment pathways—guiding escalation vs de-escalation strategies across hematologic malignancies.

To conclude the day at #DDHO2025, all speakers from the myeloma session join together for a patient-based panel discussion and Q&A—bringing clinical insights to real-world scenarios.

It’s #ASHCRTI week in LaJolla. ASH A week full of redoing study proposals, mentorship and forming life long professional friendships for participants and faculty - 28 trainees across classical and malignant hematology #ASHTrainee